HJELLE LV[au] - Search Results

Year	Number of Results
2014	1
2015	1
2016	1
2018	1
2023	2

1

Patient-reported outcomes after curative treatment for prostate cancer with prostatectomy, primary radiotherapy or salvage radiotherapy.

Sælen MG, Hjelle LV, Aarsæther E, Knutsen T, Andersen S, Bentzen AG, Richardsen E, Fosså SD, Haugnes HS. Sælen MG, et al. Among authors: hjelle lv. Acta Oncol. 2023 Jun;62(6):657-665. doi: 10.1080/0284186X.2023.2224051. Epub 2023 Jun 24. Acta Oncol. 2023. PMID: 37353983

2

The Longitudinal Course of Prospectively Recorded Patient-reported Outcomes in Prostate Cancer Patients Treated with Surgery and Salvage Radiotherapy.

Hjelle LV, Sælen M, Aarsæther E, Knutsen T, Andersen S, Bentzen AG, Richardsen E, Wilsgaard T, Fosså SD, Haugnes HS. Hjelle LV, et al. Eur Urol Open Sci. 2023 May 13;53:6-15. doi: 10.1016/j.euros.2023.04.005. eCollection 2023 Jul. Eur Urol Open Sci. 2023. PMID: 37441342 Free PMC article.

3

Long-term serum platinum changes and their association with cisplatin-related late effects in testicular cancer survivors.

Hjelle LV, Gundersen POM, Hellesnes R, Sprauten M, Brydøy M, Tandstad T, Wilsgaard T, Fosså SD, Oldenburg J, Bremnes RM, Haugnes HS. Hjelle LV, et al. Acta Oncol. 2018 Oct;57(10):1392-1400. doi: 10.1080/0284186X.2018.1473641. Epub 2018 May 18. Acta Oncol. 2018. PMID: 29775128

4

Seminoma patients treated at a minor oncological department during 1986-2010: treatment and outcome.

Haugnes HS, Solhaug Ø, Stenberg J, Hjelle LV, Bremnes RM. Haugnes HS, et al. Among authors: hjelle lv. Anticancer Res. 2014 Aug;34(8):4253-60. Anticancer Res. 2014. PMID: 25075055

5

Long-term platinum retention after platinum-based chemotherapy in testicular cancer survivors: a 20-year follow-up study.

Hjelle LV, Gundersen PO, Oldenburg J, Brydøy M, Tandstad T, Wilsgaard T, Fosså SD, Bremnes RM, Haugnes HS. Hjelle LV, et al. Anticancer Res. 2015 Mar;35(3):1619-25. Anticancer Res. 2015. PMID: 25750319

6

Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivors.

Hjelle LV, Bremnes RM, Gundersen POM, Sprauten M, Brydøy M, Tandstad T, Wilsgaard T, Fosså SD, Oldenburg J, Haugnes HS. Hjelle LV, et al. Urol Oncol. 2016 Nov;34(11):487.e13-487.e20. doi: 10.1016/j.urolonc.2016.06.012. Epub 2016 Aug 11. Urol Oncol. 2016. PMID: 27523611

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

6 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year